FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224923664> ?p ?o ?g. }

• W4224923664 endingPage "555.e3" @default.
• W4224923664 startingPage "546" @default.
• W4224923664 abstract "ObjectiveThe optimal revascularization modality following complete resection of aortic graft infection (AGI) without enteric involvement remains unclear. The purpose of this investigation is to determine the revascularization approach associated with the lowest morbidity and mortality using real-world data in patients undergoing complete excision of AGI.MethodsA retrospective, multi-institutional study of AGI from 2002 to 2014 was performed using a standardized database. Baseline demographics, comorbidities, and perioperative variables were recorded. The primary outcome was infection-free survival. Descriptive statistics, Kaplan-Meier survival analysis, and univariate and multivariable analyses were performed.ResultsA total of 241 patients at 34 institutions from seven countries presented with AGI during the study period (median age, 68 years; 75% male). The initial aortic procedures that resulted in AGI were 172 surgical grafts (71%), 66 endografts (27%), and three unknown (2%). Of the patients, 172 (71%) underwent complete excision of infected aortic graft material followed by in situ (in-line) bypass (ISB), including antibiotic-treated prosthetic graft (35%), autogenous femoral vein (neo-aortoiliac surgery) (24%), and cryopreserved allograft (41%). Sixty-nine patients (29%) underwent extra-anatomic bypass (EAB). Overall median Kaplan-Meier estimated survival was 5.8 years. Perioperative mortality was 16%. When stratified by ISB vs EAB, there was a significant difference in Kaplan-Meier estimated infection-free survival (2910 days; interquartile range, 391-3771 days vs 180 days; interquartile range, 27-3750 days; P < .001). There were otherwise no significant differences in presentation, comorbidities, or perioperative variables. Multivariable Cox regression showed lower infection-free survival among patients with EAB (hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.6-3.6; P < .001), polymicrobial infection (HR, 2.2; 95% CI, 1.4-3.5; P = .001), methicillin-resistant Staphylococcus aureus infection (HR, 1.7; 95% CI, 1.1-2.7; P = .02), as well as the protective effect of omental/muscle flap coverage (HR, 0.59; 95% CI, 0.37-0.92; P = .02).ConclusionsAfter complete resection of AGI, perioperative mortality is 16% and median overall survival is 5.8 years. EAB is associated with nearly a two and one-half-fold higher reinfection/mortality compared with ISB. Omental and/or muscle flap coverage of the repair appear protective." @default.
• W4224923664 created "2022-04-28" @default.
• W4224923664 creator A5000764818 @default.
• W4224923664 creator A5003701029 @default.
• W4224923664 creator A5007122442 @default.
• W4224923664 creator A5009856800 @default.
• W4224923664 creator A5011477558 @default.
• W4224923664 creator A5012172117 @default.
• W4224923664 creator A5013182907 @default.
• W4224923664 creator A5014406612 @default.
• W4224923664 creator A5014785844 @default.
• W4224923664 creator A5019120982 @default.
• W4224923664 creator A5020240170 @default.
• W4224923664 creator A5020414704 @default.
• W4224923664 creator A5021014320 @default.
• W4224923664 creator A5022437804 @default.
• W4224923664 creator A5024377668 @default.
• W4224923664 creator A5024854473 @default.
• W4224923664 creator A5026398032 @default.
• W4224923664 creator A5028102858 @default.
• W4224923664 creator A5028263534 @default.
• W4224923664 creator A5029419578 @default.
• W4224923664 creator A5029654150 @default.
• W4224923664 creator A5031781964 @default.
• W4224923664 creator A5033211794 @default.
• W4224923664 creator A5037191258 @default.
• W4224923664 creator A5037340806 @default.
• W4224923664 creator A5037709450 @default.
• W4224923664 creator A5038126175 @default.
• W4224923664 creator A5039998579 @default.
• W4224923664 creator A5040289186 @default.
• W4224923664 creator A5040420566 @default.
• W4224923664 creator A5041455395 @default.
• W4224923664 creator A5042429443 @default.
• W4224923664 creator A5042879168 @default.
• W4224923664 creator A5043383232 @default.
• W4224923664 creator A5048706125 @default.
• W4224923664 creator A5048717114 @default.
• W4224923664 creator A5049206580 @default.
• W4224923664 creator A5050280897 @default.
• W4224923664 creator A5050555958 @default.
• W4224923664 creator A5051539260 @default.
• W4224923664 creator A5054009251 @default.
• W4224923664 creator A5055215636 @default.
• W4224923664 creator A5056335297 @default.
• W4224923664 creator A5056608330 @default.
• W4224923664 creator A5059761788 @default.
• W4224923664 creator A5059966254 @default.
• W4224923664 creator A5060006490 @default.
• W4224923664 creator A5061350746 @default.
• W4224923664 creator A5065997886 @default.
• W4224923664 creator A5067657646 @default.
• W4224923664 creator A5068247060 @default.
• W4224923664 creator A5068922836 @default.
• W4224923664 creator A5070464285 @default.
• W4224923664 creator A5072207252 @default.
• W4224923664 creator A5073435349 @default.
• W4224923664 creator A5073880360 @default.
• W4224923664 creator A5074048639 @default.
• W4224923664 creator A5075179046 @default.
• W4224923664 creator A5075666731 @default.
• W4224923664 creator A5076389775 @default.
• W4224923664 creator A5076486381 @default.
• W4224923664 creator A5077626946 @default.
• W4224923664 creator A5079533154 @default.
• W4224923664 creator A5081027804 @default.
• W4224923664 creator A5084123187 @default.
• W4224923664 creator A5085135258 @default.
• W4224923664 creator A5088160479 @default.
• W4224923664 creator A5089306278 @default.
• W4224923664 creator A5091376707 @default.
• W4224923664 date "2022-08-01" @default.
• W4224923664 modified "2023-10-16" @default.
• W4224923664 title "In-situ bypass is associated with superior infection-free survival compared with extra-anatomic bypass for the management of secondary aortic graft infections without enteric involvement" @default.
• W4224923664 cites W1911391369 @default.
• W4224923664 cites W1963923387 @default.
• W4224923664 cites W1980130889 @default.
• W4224923664 cites W2027321177 @default.
• W4224923664 cites W2075359954 @default.
• W4224923664 cites W2085656286 @default.
• W4224923664 cites W2092418740 @default.
• W4224923664 cites W2093274439 @default.
• W4224923664 cites W2116784702 @default.
• W4224923664 cites W2328775685 @default.
• W4224923664 cites W2584588837 @default.
• W4224923664 cites W2621846645 @default.
• W4224923664 cites W2768407667 @default.
• W4224923664 cites W2776247479 @default.
• W4224923664 cites W2917415561 @default.
• W4224923664 cites W3000285033 @default.
• W4224923664 cites W3010829225 @default.
• W4224923664 cites W3131320455 @default.
• W4224923664 cites W3213654254 @default.
• W4224923664 doi "https://doi.org/10.1016/j.jvs.2022.03.869" @default.
• W4224923664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35470015" @default.
• W4224923664 hasPublicationYear "2022" @default.
• W4224923664 type Work @default.
• W4224923664 citedByCount "5" @default.

• next